MicroRNAs in the Regulation of MMPs and Metastasis

Mohammed Abba1, Nitin Patil2, Heike Allgayer3

  • 1Molecular Oncology of Solid Tumors, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany. m.abba@dkfz.de.

Cancers
|March 28, 2014
PubMed

Insights

MicroRNAs (miRNAs) regulate cell processes and impact cancer. This review explores how specific miRNAs interact with matrix metalloproteinases (MMPs) to influence cancer progression and metastasis.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are key regulators of cellular processes like differentiation, proliferation, metabolism, and apoptosis.
  • Matrix metalloproteinases (MMPs) are crucial for tissue remodeling and play significant roles in physiological and pathological processes, including cancer progression.
  • Active MMPs contribute to cancer metastasis by targeting substrates, facilitating spread and secondary tumor formation.

Purpose of the Study:

  • To review the role of specific microRNAs in cancer progression and metastasis.
  • To elucidate the direct and indirect interactions between microRNAs and matrix metalloproteinases in the context of cancer.

Main Methods:

  • Literature review of studies investigating microRNA-MMP interactions in cancer.
  • Analysis of mechanisms by which microRNAs influence MMP activity and function.
  • Examination of the impact of these interactions on cancer cell behavior and metastasis.

Main Results:

  • Identification of key microRNAs that modulate cancer progression and metastasis.
  • Detailed description of how microRNAs target or regulate matrix metalloproteinases.
  • Evidence of both direct and indirect regulatory pathways between miRNAs and MMPs in cancer.

Conclusions:

  • MicroRNAs are critical regulators of cancer progression and metastasis through their interactions with matrix metalloproteinases.
  • Targeting miRNA-MMP pathways presents a potential therapeutic strategy for cancer treatment.
  • Further research into these interactions can uncover novel biomarkers and therapeutic targets for cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

9.8K
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.9K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K